185 related articles for article (PubMed ID: 4775017)
1. [On the immunological situation seven years after the introduction into Italy of poliomyelitis vaccination with attenuated live virus vaccine].
Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
Ann Sclavo; 1973; 15(1):1-18. PubMed ID: 4775017
[No Abstract] [Full Text] [Related]
2. [Humoral immunity status against poliomyelitis in the Piedmont population 15 years after the introduction of vaccination with Sabin oral vaccine].
Giuliani G; Frezet D; Paggi GC; Varetti G
Ann Sclavo; 1982; 24(1):5-15. PubMed ID: 6303233
[No Abstract] [Full Text] [Related]
3. Antipoliomyelitis program in Brazil; a erologic study of immunity levels.
de Brito Bastos NC; Carvalho Filho ES de+CARVALHOAAFILHO ES; Schatzmayr H; Homma A; Chaves J
Bull Pan Am Health Organ; 1974; 8(1):54-65. PubMed ID: 4423450
[No Abstract] [Full Text] [Related]
4. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
[No Abstract] [Full Text] [Related]
5. [Status of immunity in the population against poliomyelitis. I].
Monaci V; Nardi G; Bellelli E
Ann Sclavo; 1971; 13(3):305-22. PubMed ID: 5153359
[No Abstract] [Full Text] [Related]
6. Poliomyelitis vaccines: an appraisal after 25 years.
Melnick JL
Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
[No Abstract] [Full Text] [Related]
7. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
Albano A; De Donato S; Scarinci V; Jakschik M
Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
[No Abstract] [Full Text] [Related]
8. Recommendations for a national policy on poliomyelitis vaccination.
Nightingale EO
N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
[TBL] [Abstract][Full Text] [Related]
9. [Antipoliomyelitic neutralizing antibodies in persons of the Milan region aged 14 to 25 years].
Braga A; Barbi M
Ann Sclavo; 1971; 13(3):323-31. PubMed ID: 4340982
[No Abstract] [Full Text] [Related]
10. [Incidence of cytopathogenic enteric viruses in Lombardy 5 years after the introduction of antipoliomyelitic vaccination with the Sabin vaccine].
Galli MG
Ann Sclavo; 1971; 13(3):362-9. PubMed ID: 4340984
[No Abstract] [Full Text] [Related]
11. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
Stagni G; Merletti L; De Rosa F
Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
[TBL] [Abstract][Full Text] [Related]
12. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
13. Poliomyelitis immunity status in Italian and foreign subjects.
Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
[No Abstract] [Full Text] [Related]
14. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
[No Abstract] [Full Text] [Related]
15. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
Kuwert E; Höher PG; Thraenhart O
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulins level in saliva of children with poliomyelitis and of healthy children after oral vaccination with live attenuated poliovirus strains type 2 and 3.
Szczepski O; Wlodarczak K; Walczak M; Walter Z; Klauziński R
Pol Med J; 1970; 9(5):1168-72. PubMed ID: 4101723
[No Abstract] [Full Text] [Related]
17. [Poliomyelitis vaccination in Denmark].
Petersen I
Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
[No Abstract] [Full Text] [Related]
18. [An epidemic episode of poliomyelitis in the City of Taranto. Virological and serological data].
Mazzotti M; Marchegiani M; Clericò N; Archetii I
Ann Ist Super Sanita; 1967; 3(3):389-91. PubMed ID: 4309083
[No Abstract] [Full Text] [Related]
19. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
[TBL] [Abstract][Full Text] [Related]
20. Poliomyelitis vaccines in Belgium: 20 years of experience.
Andre FE
Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
